Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.1K
Overview
69.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

bioRxiv : the preprint server for biology·2026
Same author

Divergent chromatin remodeling trajectories in CD66b <sup>+</sup> MDSCs distinguishes recovery from chronic critical illness after sepsis.

bioRxiv : the preprint server for biology·2026
Same author

Tumor microenvironment-targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors.

Science advances·2025
Same author

Sepsis Induces Age- and Sex-Specific Chromatin Remodeling in Myeloid-Derived Suppressor Cells.

bioRxiv : the preprint server for biology·2025
Same author

A Potent Inhibitor of Caspase‑8 Based on the IL-18 Tetrapeptide Sequence Reveals Shared Specificities between Inflammatory and Apoptotic Initiator Caspases.

ACS bio & med chem Au·2025
Same author

Design of high-specificity binders for peptide-MHC-I complexes.

Science (New York, N.Y.)·2025

相关实验视频

Updated: Jul 25, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

348

主机与工程T细胞微药房的互动

Christopher M Bourne1,2, Patrick Wallisch2,3, Megan M Dacek2,3

  • 1Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer immunology research
|June 28, 2023
PubMed
概括
此摘要是机器生成的。

合成酶武装杀伤细胞 (SEAKER) 细胞,是激活前药物的工程T细胞,对固体瘤显示出有效性. 这种在黑色素瘤模型中证明的适应性平台,对免疫能力强的宿主中各种采用细胞疗法具有前景.

更多相关视频

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K
T Cells Capture Bacteria by Transinfection from Dendritic Cells
11:39

T Cells Capture Bacteria by Transinfection from Dendritic Cells

Published on: January 13, 2016

12.0K

相关实验视频

Last Updated: Jul 25, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

348
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K
T Cells Capture Bacteria by Transinfection from Dendritic Cells
11:39

T Cells Capture Bacteria by Transinfection from Dendritic Cells

Published on: January 13, 2016

12.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 通过收养转移的T细胞对癌症治疗有希望,但由于瘤异质性和免疫逃避,与固体瘤作斗争.
  • 现有的工程T细胞,如化学抗原受体 (CAR) T细胞,在复杂的宿主环境中面临局限性.
  • 合成酶武装杀伤细胞 (SEAKER) 在淋巴瘤模型中显示出有效性,但需要在免疫能力强的宿主中测试固体瘤.

研究的目的:

  • 开发和评估T细胞受体 (TCR) 工程的SEAKER细胞,以向同基因小鼠模型中的固体瘤黑色素瘤.
  • 评估SEAKER细胞在免疫能力强的主体中的疗效和宿主相互作用.
  • 为了证明SEAKER平台对各种采用细胞疗法的广泛适用性.

主要方法:

  • 工程T细胞具有T细胞受体 (TCR) 针对黑色素瘤的特异性.
  • 将前药物激活酶功能纳入SEAKER细胞.
  • 测试SEAKER细胞疗效和瘤局部化在共生性,免疫能力较强的小鼠模型中.

主要成果:

  • 经过TCR工程的SEAKER细胞专门定位到固体瘤部位.
  • 寻找者细胞成功地在瘤微环境中激活了生物活性前药物,克服了宿主免疫反应.
  • 工程 SEAKER 细胞在免疫能力强的宿主中表现出显著的疗效,验证了它们的治疗潜力.

结论:

  • 寻找者细胞平台对固体瘤有效,即使存在宿主免疫反应.
  • 经TCR工程设计的SEAKER细胞代表了采用细胞治疗的多功能和强大的工具.
  • 这项技术对推进癌症治疗策略,特别是对固体瘤具有重大前景.